
浏览全部资源
扫码关注微信
江苏省中医院,南京中医药大学 附属医院,南京 210029
[第一作者] 吴坚,博士,助理研究员,从事脾胃病及消化肿瘤疾病研究,E-mail: czcyg @sina.com
*刘沈林,硕士,教授,主任中医师,博士生导师,从事脾胃病及消化肿瘤疾病研究,E-mail: lsljsszyy@126.com
收稿日期:2019-06-03,
网络出版日期:2019-09-18,
纸质出版日期:2020-04-05
移动端阅览
吴坚, 陈彦臻, 张星星, 等. 益气健脾化瘀方协同5-FU对胃癌的抑制作用及机制[J]. 中国实验方剂学杂志, 2020,26(7):65-72.
Jian WU, Yan-zhen CHEN, Xing-xing ZHANG, et al. Inhibitory Effect and Mechanism of Yiqi Jianpi Huayu Recipe Combined with 5-FU on Gastric Cancer[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(7): 65-72.
吴坚, 陈彦臻, 张星星, 等. 益气健脾化瘀方协同5-FU对胃癌的抑制作用及机制[J]. 中国实验方剂学杂志, 2020,26(7):65-72. DOI: 10.13422/j.cnki.syfjx.20200123.
Jian WU, Yan-zhen CHEN, Xing-xing ZHANG, et al. Inhibitory Effect and Mechanism of Yiqi Jianpi Huayu Recipe Combined with 5-FU on Gastric Cancer[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(7): 65-72. DOI: 10.13422/j.cnki.syfjx.20200123.
目的:
2
观察益气健脾化瘀方协同5-氟尿嘧啶(5-fluorouracil,5-FU)对615小鼠胃癌生长的抑制作用,并通过肿瘤微环境中的肿瘤相关巨噬细胞(tumor-associated macrophages
TAMs)极化方向,探讨其可能的作用机制。
方法:
2
40只615小鼠随机分为正常组,益气健脾化瘀方(25 g·kg
-1
)组,5-FU(25 mg·kg
-1
)组,联合(益气健脾化瘀方25 g·kg
-1
+5-FU 25 mg·kg
-1
)组,每组10只。腋下接种MFC胃癌细胞建立小鼠胃癌移植瘤模型。苏木素-伊红(hematoxylin-eosin staining,HE)染色法观察各组小鼠肿瘤病理的改变;流式细胞仪测定肿瘤组织中M1,M2型TAMs含量;免疫组化观察腋下移植瘤中CD206的表达;实时荧光定量PCR(Real-time PCR)检测瘤组织中TAMs相关基因白细胞介素-1
β
(interleukin-1
β
,IL-1
β
),白细胞介素-12(interleukin-12,IL-12),肿瘤坏死因子-
α
(tumor necrosis factor-
α
,TNF-
α
),精氨酸酶1(arginase-1,Arg1),几丁质酶3蛋白3(chitinase 3-like 3,Ym1)的mRNA表达水平。Real-time PCR,蛋白免疫印迹法(Western blot)检测瘤组织中上皮间质转化(epithelial mesenchymal transformation,EMT)相关上皮性钙黏附蛋白(E-cadherin),神经性钙黏附蛋白(N-cadherin),锌指转录因子Slug,Snail,波形蛋白(Vimentin)mRNA及蛋白的表达。
结果:
2
各组小鼠胃癌细胞排列呈巢状及片状,细胞间质见促纤维结缔组织反应及少量炎症细胞浸润。各药物组可见明显肿瘤凝固性坏死,残留肿瘤细胞量正常组
>
益气健脾化瘀方组
>
5-FU组
>
联合组。免疫组化表明,各给药组均能减少瘤体CD206的表达,以联合组最明显。流式细胞仪检测证实,与正常组比较,各给药组均能减少M2型TAMs的含量(
P
<
0.05,
P
<
0.01),联合组减少M2型TAMs的含量最明显;益气健脾化瘀方组、联合组均能增加M1型TAMs的含量(
P
<
0.05,
P
<
0.01),以益气健脾化瘀方组最为明显。与正常组比较,益气健脾化瘀方组、联合组均能下调Arg1,Ym1 mRNA,上调IL-1
β
,TNF-
α
,IL-12 mRNA表达(
P
<
0.05)。与5-FU组比较,联合组能明显升高IL-1
β
,IL-12,TNF-
α
mRNA,下调Arg1,Ym1 mRNA表达(
P
<
0.05)。与正常组比较,益气健脾化瘀方组能上调E-cadherin mRNA及蛋白表达(
P
<
0.05),下调N-cadherin,Vimentin mRNA表达(
P
<
0.05);联合组能上调E-cadherin,下调N-cadherin,Slug,Snail,Vimentin mRNA表达(
P
<
0.05),上调E-cadherin,下调N-cadherin,Slug蛋白表达(
P
<
0.01)。与5-FU组比较,联合组能上调肿瘤组织中E-cadherin,下调N-cadherin,Slug,Vimentin mRNA及蛋白表达(
P
<
0.05)。
结论:
2
益气健脾化瘀方对胃癌生长有一定的抑制作用,与5-FU联用有较好的协同抑制胃癌生长、改善胃癌上皮间质转化,机制可能与促进胃癌中TAMs从M2表型向M1表型转化有关。
Objective:
2
To observe the synergistic effect and mechanism of Yiqi Jianpi Huayu (YQJPHY) recipe combined with 5-fluorouracil (5-FU) on inhibiting gastric cancer growth
and investigate its possible mechanism through polarization direction of tumor-associated macrophages (TAMs) in tumor micro-environment.
Method:
2
A total of forty 615 mice were randomly divided into four groups including control group
YQJPHY(25 g·kg
-1
) group
5-FU (25 mg·kg
-1
) group and combined group (YQJPHY plus 5-FU)
with 10 mice in each group. The gastric cancer transplantation model was induced by axillary inoculation of MFC gastric cancer cells. Changes in tumor pathology were observed with hematoxylin-eosin staining (HE) method. The contents of M1 and M2 TAMs in tumor tissues were determined with flow cytometry
while the expression of CD206 in tumor was observed with immunohistochemistry. The mRNA expressions of TAM-related genes including interleukin-1
β
(IL-1
β
)
interleukin-12(IL-12)
tumor necrosis factor-
α
(TNF-
α
)
arginase-1(Arg1)
and chitinase 3-like 3(Ym1) were detected by using quantitative real-time polymerase chain reaction (Real-time PCR). Furthermore
the mRNA and protein expressions of epithelial-mesenchymal transition (EMT) related epithelial calcium adhesion protein(E-cadherin)
nervous calcium adhesion protein(N-cadherin)
Zinc finger transcription factor Slug
Snail and Waveform protein (Vimentin) were detected with Real-time PCR and Western blot
respectively.
Result:
2
The gastric cancer cells in tumors were distributed in nest and/or flaky shape
with fibroblastic connective tissue reaction and inflammatory cells infiltrated in interstitium. Coagulative necrosis of tumor was observed in various treatment groups. The amount of residual cancer cells in mouse was as follows from largest to smallest: control group
>
YQJPHY group
>
5-FU group
>
combined group. Immunohistochemical studies showed that all treatment groups can reduce the expression of CD206 in the tumor
and the effect was most obvious in the combined group. The contents of M2-TAM in all treatment groups were lower than those in control group(
P
<
0.05
P
<
0.01)
and the most significant difference in the content of M2-TAMs was shown between the control group and the combined group. The contents of M1 TAMs were increased in YQJPHY and combined groups(
P
<
0.05
P
<
0.01)
with the largest incremental range in YQJPHY group. The expressions of Arg1 and Ym1 in YQJPHY and combined groups were lower
while IL-1
β
TNF-
α
and IL-12 levels were higher than those in control group(
P
<
0.05). The mRNA expressions of IL-1
β
IL-12 and TNF-
α
in the combined group were significantly higher
while Arg1 and Ym1 mRNA expression levels were lower than those in the 5-FU group(
P
<
0.05). As compared with the control group
the mRNA and protein expression levels of E-cadherin were up-regulated(
P
<
0.05)
while the mRNA expression levels of N-cadherin and Vimentin were down-regulation in the YQJPHY group (
P
<
0.05)
E-cadherin mRNA and protein expression levels were up-regulated
while N-cadherin
Slug
Snail
Vimentin mRNA expression as well as N-cadherin and Slug protein expression levels were down-regulated in the combined group(
P
<
0.05). As compared with the 5-FU group
the mRNA and protein expression levels of E-cadherin were up-regulated(
P
<
0.05)
while the mRNA and protein expression levels of N-cadherin
Slug and Vimentin were down-regulated in the combined group(
P
<
0.05).
Conclusion:
2
YQJPHY has an inhibitory effect on the growth of gastric cancer
and after being combined with 5-FU
it has a good synergistic effect on inhibiting the growth of gastric cancer and decreasing EMT. The mechanism may be related to promoting the conversion from M2-TAMs to M1-TAMs in gastric tumor micro-environment.
Z LI , H LEI , M LUO , et al . DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer [J]. Gastric Cancer , 2015 , 18 ( 1 ): 43 - 54 .
A I ROZHOK , J DEGREGORI . Toward an evolutionary model of cancer: considering the mechanisms that govern the fate of somatic mutations [J]. Proc Natl Acad Sci USA , 2015 , 112 ( 29 ): 8914 - 8921 .
陈璐 , 高威 . 肿瘤酸性微环境的形成机制及其对肿瘤进展的影响 [J]. 肿瘤 , 2019 , 39 ( 2 ): 140 - 145 .
R NOY , J W POLLARD . Tumor-associated macrophages: from mechanisms to therapy [J]. Immunity , 2014 , 41 ( 1 ): 49 - 61 .
R A FRANKLIN , W LIAO , A SARKAR , et al . The cellular and molecular origin of tumor-associated macrophages [J]. Science , 2014 , 344 ( 6186 ): 921 - 925 .
T YAMAGUCHI , S FUSHIDA , Y YAMAMOTO , et al . Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination [J]. Gastric Cancer , 2016 , 19 ( 4 ): 1052 - 1065 .
M DE PALMA , C E LEWIS . Macrophage regulation of tumor responses to anticancer therapies [J]. Cancer Cell , 2013 , 23 ( 3 ): 277 - 286 .
S K BISWAS . Metabolic reprogramming of immune cells in cancer progression [J]. Immunity , 2015 , 43 ( 3 ): 435 - 449 .
K SAWA-WEJKSZA , M KANDEFER-SZERSZEN . Tumor-associated macrophages as target for antitumor therapy [J]. Arch Immunol Ther Exp (Warsz) , 2018 , 66 ( 2 ): 97 - 111 .
王敏 , 刘沈林 , 吴坚 , 等 . 益气健脾化瘀方联合5-FU对MFC荷瘤小鼠皮下移植瘤的生长及免疫功能的影响 [J]. 中国实验方剂学杂志 , 2019 , 25 ( 6 ): 65 - 72 .
A SICA , C PORTA , A AMADORI , et al . Tumor-associated myeloid cells as guiding forces of cancer cell stemness [J]. Cancer Immunol Immunother , 2017 , 66 ( 8 ): 1025 - 1036 .
王惠 , 徐陆周 , 吴坚 , 等 . 理冲汤加减联合5-氟尿嘧啶对人肝癌细胞HepG2上皮间质转化的影响 [J]. 中国实验方剂学杂志 , 2019 , 25 ( 7 ): 14 - 21 .
邹玺 , 陈玉超 , 胡守友 , 等 . 健脾养正消癥方对胃癌患者晚期生存期和生活质量的影响 [J]. 南京中医药大学学报 , 2015 , 31 ( 3 ): 201 - 205 .
胥孜杭 , 张飞 , 朱杨壮壮 , 等 . 肿瘤微环境中不同亚型的髓源抑制性细胞及中医药对其调控作用的研究进展 [J]. 中国实验方剂学杂志 , 2019 , 25 ( 14 ): 45 - 54 .
X LI , W YAO , Y YUAN , et al . Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signaling as a therapeutic strategy against hepatocellular carcinoma [J]. Gut , 2017 , 66 ( 1 ): 157 - 167 .
L A BORTHWICK , E I MCILROY , M R GOROWIEC , et al . Inflammation and epithelial to mesenchymal transition in lung transplant recipients: role in dysregulated epithelial wound repair [J]. Am J Transplant , 2010 , 10 ( 3 ): 498 - 509 .
A K BONDE , V TISCHLER , S KUMAR , et al . Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors [J]. BMC Cancer , 2012 , 12 ( 1 ): 35 - 36 .
M ERRENI , A MANTOVANI , P ALLAVENA . Tumor-associated macrophages (TAM) and inflammation in colorectal cancer [J]. Can Microenviron , 2011 , 4 ( 2 ): 141 - 154 .
0
浏览量
17
下载量
1
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621